Mild hearing loss is common among people with ankylosing spondylitis, particularly in older…
Articles by Alice Melao
Inhibiting both IL-17A and IL-17F signaling molecules with the investigational antibody bimekizumab can effectively improve the outcomes of patients…
Progressing disease, older age, and lower education can significantly affect ankylosing spondylitis patients’ ability to cope with the challenges and…
A high-fat diet and long-term exposure to air pollution are both associated with worse outcomes in patients with ankylosing…
Treatment with anti-TNF-alpha therapies can lead to improved lumbar spine curvature and better clinical outcomes in patients with ankylosing spondylitis,…
Determining blood levels of two proteins — osteoprotegerin (OPG) and receptor activator of nuclear factor-kB ligand (RANKL) — may help…
Analyzing the circulating levels of a specific RNA molecule, known as MEG3, may be used as a reliable and effective biomarker for…
People with ankylosing spondylitis have diminished health-related quality of life (HRQoL) compared to the general population, a Swedish study shows.
Approximately 10 to 23 percent of people with ankylosing spondylitis have hip joint involvement that can be managed with tumor…
TrialSpark, a technology company that works to increase access and integrate trial participation into patients’ everyday lives, has teamed up with…